MedCAD
Innovative 3D printing technology for facial reconstruction
- CEO / Founder
- Nancy Hairston
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- $1.62M
- Latest Round
- Debt
- Key Investors
- Paycheck Protection Program
Technology & Products
Key Products
["Facial reconstruction implants","Custom 3D printed facial prosthetics"]
Technological Advantage
Enhanced precision and customization in reconstructive procedures.
Differentiation
Value Proposition
Advanced 3D printing technology improves the accuracy and speed of facial reconstruction procedures.
How They Differentiate
Innovative application of 3D printing technology tailored for facial reconstruction.
Market & Competition
Target Customers
Medical professionals and patients requiring facial reconstruction
Industry Verticals
["Medical technology","Reconstructive surgery"]
Competitors
Stryker; Zimmer Biomet; Materialise
Growth & Milestones
Growth Metrics
MedCAD has provided facial, mandibular, and cranial implants for more than 8,000 patients as of December 2024. Annual revenue is between $10 million and $20 million (2025 and projected 2026); the company is profitable but did not disclose exact profit figures. Founded in 2007, MedCAD pivoted to medical 3D printing by 2009 and received FDA 510(k) clearances in 2019 for AccuPlate mandibular reconstruction and 3D-printed titanium implants.
Major Milestones
["Recent unveiling of significant advancements in facial reconstruction technology using 3D printing"]
Notable Customers
Dr. Gaurav Shah; Dr. Samir Singh; Christian Medical Association of Ukraine